Home NDC 68071-5173-4 Codeine-Guaifenesin
Product NDC 68071-5173
Requested package NDC 68071-5173-4
11-digit product format 680715173
Labeler code 68071
Product ID 68071-5173_1b56a7bc-e859-d8c7-e063-6294a90a5ee1
Type HUMAN OTC DRUG
Nonproprietary name Codeine Phosphate and Guaifenesin
Dosage form SOLUTION
Route ORAL
Labeler NuCare Pharmaceuticals,Inc.
Application M013
Marketing category OTC MONOGRAPH DRUG
Marketing start 2014-04-01
Substance CODEINE PHOSPHATE; GUAIFENESIN
Active strength 10; 100 mg/5mL; mg/5mL
Pharmacologic classes Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Full Opioid Agonists [MoA], Increased Respiratory Secretions [PE], Opioid Agonist [EPC]
DEA schedule CV
NDC exclude flag No
Listing certified through 2027-12-31
Current FDA listing Yes Observed NDC auxiliary status history# This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
Historic NDC status page 1 of 1 · 3 matching rows.
View current auxiliary records. · View the auxiliary file history.
Captured / source date, Dataset, Scope table Captured / source date Dataset Scope Product NDC Package NDC Code Status Reporting period Archive Snapshot Source SHA-256 2024-05-28 21:12 UTC · source 2024-05-28 excluded package package 68071-5173 68071-5173-4 I Inactivated by FDA excluded / ndc_excluded.zip 8af77b9d5b6f…d9bbb34c5368…2024-05-15 03:39 UTC · source 2024-05-14 excluded package package 68071-5173 68071-5173-4 I Inactivated by FDA excluded / ndc_excluded.zip 834df4deac94…adcc014656a3…2024-03-11 06:39 UTC · source 2024-03-08 excluded package package 68071-5173 68071-5173-4 I Inactivated by FDA excluded / ndc_excluded.zip 1332a3947898…d4bfe170f9cd…
Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
Finished product Yes
Brand name base Codeine-Guaifenesin
Listing expiration 2027-12-31 Active Ingredients# Ingredient, Strength table Ingredient Strength CODEINE PHOSPHATE 10 mg/5mL GUAIFENESIN 100 mg/5mL
Harmonized UNII identifiers# UNII identifiers page 1 of 1 · 2 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination GSL05Y1MN6 Internal UNII lookup 495W7451VQ Internal UNII lookup
Harmonized RxCUI identifiers# RxCUI identifiers page 1 of 1 · 1 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination 995868 Internal RxNorm lookup
Harmonized SPL set identifiers# SPL set identifiers page 1 of 1 · 1 matching rows.
DailyMed Product Concepts# FDA-Initiated Inactive NDC Indexing# DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 68071-5173-4 Codeine-Guaifenesin 120 mL in 1 BOTTLE SOLUTION 120 3
DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 68071-5173 CODEINE-GUAIFENESIN (CODEINE PHOSPHATE AND GUAIFENESIN) SOLUTION [NUCARE PHARMACEUTICALS,INC.] 3 Current NDC, Legacy NDC, 1 package rows 20240627_9e691264-d48a-6b48-e053-2995a90a9352.zip
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 6 of 83 · 1,655 matching rows.
Brand, Generic, Manufacturer table Brand Generic Manufacturer SPL set ID Effective date Available safety fields Join Aspirin ASPIRIN Meijer Distribution, Inc. 815a70e4-525c-4015-8d3b-83dbb979a66f 2026-10-02 Warnings Exact identifier application number: M013 Mejoralito Children CHILDREN ACETAMINOPHEN OPMX LLC 499e2334-fe7b-ed75-e063-6294a90a3e4c 2026-10-02 Warnings Exact identifier application number: M013 DOLODOL ACETAMINOPHEN, ASPIRIN, CAFFEINE OPMX LLC 4c3544bb-058d-4585-e063-6394a90a79f4 2026-10-02 Warnings Exact identifier application number: M013 Mejoralito Children ACETAMINOPHEN OPMX LLC 5464188d-0137-033e-e063-6294a90ace66 2026-10-02 Warnings Exact identifier application number: M013 Neo-Lubrina Children ACETAMINOPHEN OPMX LLC 5476f4cf-4a5d-2287-e063-6394a90a5ed5 2026-10-02 Warnings Exact identifier application number: M013 DESENFRIOL-ITO PLUS ACETAMINOPHEN OPMX LLC 544ee7bd-0c95-2485-e063-6294a90a98c7 2026-10-02 Warnings Exact identifier application number: M013 Acetaminophen ACETAMINOPHEN Rising Pharma Holdings, Inc. bd5e6804-4df4-4a65-92e4-faa3a0f7c005 2026-10-02 Warnings Exact identifier application number: M013 Meijer Childrens Pain and Fever Reducer ACETAMINOPHEN MEIJER DISTRIBUTION INC b416857a-22d5-4504-9bbc-69ab5429654d 2026-10-01 Warnings Exact identifier application number: M013 Children Pain and Fever Reliever ACETAMINOPHEN MEIJER DISTRIBUTION INC 60012b2b-1c73-4b5f-92de-b6794f7b33ab 2026-10-01 Warnings Exact identifier application number: M013 welby acetaminophen ACETAMINOPHEN Aldi, Inc 7e09702c-52d4-490d-a320-13a1ab422100 2026-10-01 Warnings Exact identifier application number: M013 Aspirin ASPIRIN Athlete's Needs Inc d8b5d5b4-44d2-4f8f-8c11-e4fc96504f59 2026-10-01 Warnings Exact identifier application number: M013 Acetaminophen PM ACETAMINOPHEN, DIPHENHYDRAMINE HCL COSTCO WHOLESALE CORPORATION e03dfa65-1a9c-4284-89cf-19ccbaabfa32 2026-10-01 Warnings Exact identifier application number: M013 Back and Body Extra Strength ASPIRIN, CAFFEINE L.N.K. International, Inc. 6d254f3f-8223-4a6e-a3b2-f53f145ff3dc 2026-10-01 Warnings Exact identifier application number: M013 Headache Relief ACETAMINOPHEN, ASPIRIN, CAFFEINE L.N.K. International, Inc. e51fc0d6-9b32-478c-bab7-328013e692b0 2026-09-30 Warnings Exact identifier application number: M013 Pain and Fever Childrens ACETAMINOPHEN Wal-Mart Stores Inc 1729d4b1-ca3b-4360-8328-2484f239440a 2026-09-29 Warnings Exact identifier application number: M013 DOLONEURO-TROPAS ACETAMINOPHEN, CAFFEINE OPMX LLC 4c4b0d8c-3195-7d7b-e063-6294a90a8c42 2026-09-29 Warnings Exact identifier application number: M013 DOLONEURO-TROPAS ACETAMINOPHEN, CAFFEINE OPMX LLC 31bb39f4-3b7e-c983-e063-6294a90abccd 2026-09-29 Warnings Exact identifier application number: M013 Buscapina ACETAMINOPHEN, CAFFEINE AND PYRILAMINE MALEATE OPMX LLC 436b3716-1c87-bfba-e063-6394a90a1e12 2026-09-29 Warnings Exact identifier application number: M013 Crocin MAX ACETAMINOPHEN OPMX LLC 498c7d7e-d952-c122-e063-6394a90ae72f 2026-09-29 Warnings Exact identifier application number: M013 Resfriol-ito Children ACETAMINOPHEN OPMX LLC 49a27970-f497-934d-e063-6394a90a08d9 2026-09-29 Warnings Exact identifier application number: M013
DailyMed RxNorm Mappings# Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Units Marketing start Marketing end Sample Exclude flag Status 68071-5173-4 68071517304 120 mL in 1 BOTTLE (68071-5173-4) 120 ml 2020-02-12 0000-00-00 No No Current